Alloreactive (CD4-independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts

K. E. Lunsford, K. Jayanshankar, A. M. Eiring, P. H. Horne, M. A. Koester, D. Gao, G. L. Bumgardner

    Research output: Contribution to journalArticlepeer-review

    13 Scopus citations


    Despite success of early islet allograft engraftment and survival in humans, late islet allograft loss has emerged as an important clinical problem. CD8+ T cells that are independent of CD4+ T cell help can damage allograft tissues and are resistant to conventional immunosuppressive therapies. Previous work demonstrates that islet allografts do not primarily initiate rejection by the (CD4-independent) CD8-dependent pathway. This study was performed to determine if activation of alloreactive CD4-independent, CD8+ T cells, by exogenous stimuli, can precipitate late loss of islet allografts. Recipients were induced to accept intrahepatic islet allografts (islet 'acceptors') by short-term immunotherapy with donor-specific transfusion (DST) and anti-CD154 mAb. Following the establishment of stable long-term islet allograft function for 60-90 days, recipients were challenged with donor-matched hepatocellular allografts, which are known to activate (CD4-independent) CD8+ T cells. Allogeneic islets engrafted long-term were vulnerable to damage when challenged locally with donor-matched hepatocytes. Islet allograft loss was due to allospecific immune damage, which was CD8- but not CD4-dependent. Selection of specific immunotherapy to suppress both CD4- and CD8-dependent immune pathways at the time of transplant protects islet allografts from both early and late immune damage.

    Original languageEnglish (US)
    Pages (from-to)1113-1128
    Number of pages16
    JournalAmerican Journal of Transplantation
    Issue number6
    StatePublished - Jun 2008


    • CD4 T cells
    • CD40 ligand
    • CD8 T lymphocytes
    • Cell-mediated cytotoxicity
    • Cellular transplantation
    • Costimulation blockade
    • Cytotoxic T cells
    • Delayed-type hypersensitivity
    • Donor-specific transfusion
    • Effector mechanisms

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Transplantation
    • Pharmacology (medical)


    Dive into the research topics of 'Alloreactive (CD4-independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts'. Together they form a unique fingerprint.

    Cite this